25 mg töflur. clinical trials

Danish trial of beta blocker treatment after myocardial infarction without reduced ejection fraction (DANBLOCK)

This study, called DANBLOCK, is looking into whether common heart medications called beta-blockers help people who have had a heart attack but whose heart is still pumping well. It aims to see if these medications can prevent future heart problems and improve overall health.